✦ LIBER ✦

Anti-tumor immune responses and tumor regression induced with mimotopes of a tumor-associated T cell epitope

✍ Scribed by Sherev Tumenjargal; Sylke Gellrich; Thomas Linnemann; J. Marcus Muche; Ansgar Lukowsky; Heike Audring; Karl-Heinz Wiesmüller; Wolfram Sterry; Peter Walden

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 418 KB
Volume: 33
Category: Article
ISSN: 0014-2980
DOI: 10.1002/eji.200324244

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Triggering of TNFRSF25 promotes CD8+ T-c

Triggering of TNFRSF25 promotes CD8+ T-cell responses and anti-tumor immunity

✍ Tomasz J. Slebioda; Tania F. Rowley; John R. Ferdinand; Jane E. Willoughby; Sara 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB 👁 1 views

## Abstract TNFRSF25 is a member of the TNF receptor superfamily (TNFRSF) that binds to the TNF‐like protein TL1A. Although recent studies have demonstrated a role for TNFRSF25 in regulating CD4^+^ T‐cell responses, it remains to be determined if TNFRSF25 functions as a costimulatory receptor for C

HER-2/neu antigen loss and relapse of ma

HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses

✍ Maciej Kmieciak; Keith L. Knutson; Catherine I. Dumur; Masoud H. Manjili 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 1 views

T cell-mediated immunity to oncornavirus

T cell-mediated immunity to oncornavirus-induced tumors IV. Preliminary evidence for a specific suppression of anti-Moloney cell-mediated immune response by autoimmune T cells

✍ Jean-Claude Leclerc; Christine Plater; Francine Connan; Patrice Debré 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB 👁 1 views

Paradoxical enhancement of CD8 T cell-de

Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine

✍ Dev Karan; Arthur M. Krieg; David M. Lubaroff 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 371 KB 👁 1 views

## Abstract Generation of antigen‐specific CD8+ T cell responses is considered optimal for an effective immunotherapy against cancer. In this study, we provide a proof of principle that __in vitro__ observed diminished CD8+ T cell response provided a strong __in vivo__ tumor protection. Immunizatio

A Fully Synthetic Vaccine Consisting of

A Fully Synthetic Vaccine Consisting of a Tumor-Associated Glycopeptide Antigen and a T-Cell Epitope for the Induction of a Highly Specific Humoral Immune Response

✍ Sebastian Dziadek; Alexandra Hobel; Edgar Schmitt; Horst Kunz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 2 views

Vaccination of tumor cells transfected w

Vaccination of tumor cells transfected with the B7-1 (CD80) gene induces the anti-metastatic effect and tumor immunity in mice

✍ Hideki Fujii; Manabu Inobe; Fuminari Kimura; Jun Murata; Masaaki Murakami; Yasuh 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 766 KB

The present study demonstrates that the transfection of B7-I or its variant MB7-2 genes into MHC class I+ tumor cells (B 16-BL6 or K I 735-M2 melanoma) resulted in the remarkable reduction of lung metastasis caused by i.v. injection into immunocompetent syngeneic mice. However, i.v. injection of the